UK Artificial Tear Market Reaches $151.1 Million in 2025 with 5.8% CAGR

UK artificial tear market was valued at $151.1 million in 2025 and is projected to reach $259.8 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026–2035). Artificial tears are a core component of dry eye disease (DED) management and are widely used to alleviate symptoms such as ocular dryness, irritation, burning, and visual fatigue. The market encompasses a broad range of products, including preservative-free formulations, hyaluronic acid–based drops, lipid-enhanced emulsions, gels, and ointments, designed for varying severities of ocular surface disorders. Growth is being driven by the rising prevalence of dry eye linked to aging demographics, extensive digital device usage, increased contact lens wear, and heightened patient awareness of eye health.

Browse the full report description of “UK Artificial Tears Market Size, Share & Trends Analysis Report by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Oil-Based Emulsion Tears, and Polyethylene Glycol- & Propylene Glycol-Based Tears), By Delivery Method (Eyedrops and Ointments/Gel), By Application (Dry Type Treatment, Contact Lens Moisture, and Digital Eye Strain) and By End-User (Retail Pharmacies (OTC), Online Pharmacies, Hospitals & Ophthalmic Clinics, and Other End User) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/uk-artificial-tears-market

The UK market is witnessing consistent expansion, supported by strong ophthalmology and optometry services, widespread access to over-the-counter eye care products, and growing adoption of long-term, maintenance-based dry eye therapies. Key trends shaping the market include increasing demand for preservative-free and multi-dose sterile delivery systems, preference for clinically validated and NHS-recommended products, and rising use of lipid-based and hyaluronic acid formulations for moderate to severe and evaporative dry eye.

According to PMC and the UK National Health Service (NHS) clinical data, dry eye disease (DED) the principal condition treated with artificial tears affects a substantial portion of the UK population, leading to increased reliance on artificial tear products by patients, optometrists, and primary care providers.

Key Innovators Driving UK Artificial Tear Transformation

The key players in the UK artificial tear market include AbbVie?Inc., Alcon Inc., Bausch +?Lomb Corporation, Johnson & Johnson Vision, Santen Pharmaceutical Co., Ltd., among others. These companies are actively advancing preservative-free technologies, lipid-layer stabilizing formulations, and next-generation ocular drug delivery platforms, shaping the future of dry eye management in UK.

• In August 2025, Théa Pharmaceuticals expanded its UK artificial tear portfolio with the launch of a preservative-free hyaluronic acid formulation in a multi-dose bottle, targeting patients with moderate to severe dry eye. The introduction reinforces the UK market’s strong shift toward preservative-free ophthalmic solutions.
• In July 2025, Alcon strengthened its UK presence by introducing an upgraded lipid-based emulsion eye drop specifically developed for evaporative dry eye associated with meibomian gland dysfunction, reflecting growing clinical emphasis on subtype-specific treatment approaches.
• In June 2025, Bayer partnered with a UK ophthalmology research institute to evaluate next-generation gel-based artificial tear technologies aimed at providing longer-lasting symptom relief, highlighting continued investment in advanced ocular surface research in the UK.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • Delivery Method
  • By Application
  • By End-User
• Competitive Landscape - AbbVie?Inc., Alcon Inc., Bausch +?Lomb Corporation, Johnson & Johnson Vision, Santen Pharmaceutical Co., Ltd., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

UK Artificial Tear Market Report Segment

By Type

• Cellulose-Derived Tears
• Glycerin-Derived Tears
• Oil-Based Emulsion Tears
• Polyethylene Glycol- & Propylene Glycol-Based Tears

By Delivery Method

• Eyedrops
• Ointments/Gel

By Application

• Dry Type Treatment
• Contact Lens Moisture
• Digital Eye Strain

By End-User

• Retail Pharmacies (OTC)
• Online Pharmacies
• Hospitals & Ophthalmic Clinics
• Other End User

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-artificial-tears-market